NYSE$EW
Edwards Lifesciences Corp · Q1 2019 earnings
Q1 2019 earnings · · Investor relations
Headline financials
Revenue & EPS history
Edwards Lifesciences · Revenue · Quarterly
$993M
Q1 2019+11%vs Q1 2018
Revenue by segment
Edwards Lifesciences · $817M total across 3 segments · Q1 2019
- Transcatheter Aortic Valve Replacement$598M—73.2%
- Surgical Structural Heart$215M—26.3%
- Transcatheter Mitral & Tricuspid$4.3M—0.5%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2019
-1.3%
Avg return
Earnings day
-2.1%
Avg return
5 days after
-1.5%
Avg return
30 days after
50%
35 / 70 earnings
Positive
+11.6%
Q1 2017
Best reaction
-31.4%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.1% | +1.9% | +7.7% | |
| Q4 2025 | +3.0% | -1.5% | +6.2% | |
| Q3 2025 | -0.8% | -0.8% | +3.8% | |
| Q2 2025 | +0.1% | +4.1% | -0.8% | |
| Q1 2025 | +6.6% | +8.3% | +6.4% | |
| Q4 2024 | +6.9% | +7.4% | -2.3% | |
| Q3 2024 | -1.7% | -1.8% | -0.2% | |
| Q2 2024 | -31.4% | -26.8% | -18.6% | |
| Q1 2024 | -2.5% | -4.4% | -0.7% | |
| Q4 2023 | +0.6% | -1.2% | +9.0% | |
| Q3 2023 | -10.9% | -11.5% | -3.7% | |
| Q2 2023 | -9.8% | -10.5% | -16.9% | |
| Q1 2023 | -1.2% | -0.3% | -6.6% | |
| Q4 2022 | +7.1% | +8.0% | +5.5% | |
| Q3 2022 | -18.3% | -16.3% | -12.0% | |
| Q2 2022 | -4.8% | -3.2% | -13.6% | |
| Q1 2022 | -8.3% | -11.7% | -17.7% | |
| Q4 2021 | -6.9% | -0.3% | +3.2% | |
| Q3 2021 | -0.4% | -1.2% | -6.4% | |
| Q2 2021 | +2.0% | +4.2% | +5.8% | |
| Q1 2021 | +7.5% | +10.0% | +4.8% | |
| Q4 2020 | -3.7% | -5.3% | -4.0% | |
| Q3 2020 | -6.0% | -7.5% | +0.1% | |
| Q2 2020 | +0.3% | -0.6% | +1.0% | |
| Q1 2020 | +3.2% | -1.6% | +1.1% | |
| Q4 2019 | -5.5% | -2.7% | -12.0% | |
| Q3 2019 | +3.0% | +6.8% | +8.4% | |
| Q2 2019 | +10.8% | +9.7% | +11.7% | |
| Q1 2019 | -0.3% | -1.2% | -4.7% | |
| Q4 2018 | -0.0% | +0.8% | +2.9% | |
| Q3 2018 | -6.0% | -6.1% | -0.7% | |
| Q2 2018 | -8.5% | -8.2% | -8.6% | |
| Q1 2018 | -5.6% | -5.8% | +0.3% | |
| Q4 2017 | +4.1% | +0.4% | +6.3% | |
| Q3 2017 | -9.4% | -10.7% | -4.6% | |
| Q2 2017 | +0.4% | -0.6% | -3.5% | |
| Q1 2017 | +11.6% | +12.0% | +16.5% | |
| Q4 2016 | -6.8% | -6.6% | -3.9% | |
| Q3 2016 | -19.5% | -17.8% | -25.8% | |
| Q2 2016 | +7.4% | +7.5% | +7.7% | |
| Q1 2016 | +0.9% | — | — | |
| Q4 2015 | +5.7% | — | — | |
| Q3 2015 | +0.7% | — | — | |
| Q2 2015 | +0.7% | — | — | |
| Q1 2015 | -1.8% | — | — | |
| Q4 2014 | +7.5% | — | — | |
| Q3 2014 | +10.9% | — | — | |
| Q2 2014 | +9.4% | — | — | |
| Q1 2014 | +0.7% | — | — | |
| Q4 2013 | +1.0% | — | — | |
| Q3 2013 | -9.3% | — | — | |
| Q2 2013 | +2.3% | — | — | |
| Q1 2013 | -22.8% | — | — | |
| Q4 2012 | -7.1% | — | — | |
| Q3 2012 | -0.3% | — | — | |
| Q2 2012 | +4.5% | — | — | |
| Q4 2011 | -1.6% | — | — | |
| Q1 2012 | +11.6% | — | — | |
| Q3 2011 | -5.9% | — | — | |
| Q2 2011 | -3.5% | — | — | |
| Q4 2010 | +0.5% | — | — | |
| Q1 2010 | +0.5% | — | — | |
| Q1 2011 | -2.1% | — | — | |
| Q4 2008 | -1.7% | — | — | |
| Q1 2009 | -1.7% | — | — | |
| Q3 2010 | +1.3% | — | — | |
| Q3 2009 | +1.3% | — | — | |
| Q2 2009 | +1.3% | — | — | |
| Q2 2010 | +1.3% | — | — | |
| Q4 2009 | +1.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro